Pharmacoeconomic review report: Cyclosporine (Verkazia) (Santen Canada inc.) indication: treatment of severe vernal keratoconjunctivitis in children from four years of age through adolescence

The key clinical outcome in the model was the Quality of Life in Children with Vernal Keratoconjunctivitis (QUICK) questionnaire score. Specifically, patients in the symptomatic health state accrued treatment-specific utility decrements based on mapping QUICK questionnaire VKC symptoms domain scores...

Full description

Bibliographic Details

Corporate Author:	Canadian Agency for Drugs and Technologies in Health
Format:	eBook
Language:	English
Published:	Ottawa (ON) Canadian Agency for Drugs and Technologies in Health 2020, January 2020
Edition:	Version: final
Series:	CADTH common drug review
Online Access:	https://www.ncbi.nlm.nih.gov/books/NBK558372
Collection:	National Center for Biotechnology Information - Collection details see MPG.ReNa